4X80
Crystal Structure of murine 7B4 Fab monoclonal antibody against ADAMTS5
Summary for 4X80
Entry DOI | 10.2210/pdb4x80/pdb |
Related | 4X8J |
Descriptor | IgG1 7B4 FAB Light Chain, IgG1 7B4 FAB Heavy chain (3 entities in total) |
Functional Keywords | monoclonal, immune system |
Biological source | Mus musculus More |
Total number of polymer chains | 2 |
Total formula weight | 47693.81 |
Authors | Larkin, J.,Lohr, T.A.,Elefante, L.,Shearin, J.,Matico, R.,Su, J.-L.,Xue, Y.,Liu, F.,Genell, C.,Miller, R.E.,Tran, P.B.,Malfait, A.-M.,Maier, C.C.,Matheny, C.J. (deposition date: 2014-12-09, release date: 2015-04-08, Last modification date: 2024-11-06) |
Primary citation | Larkin, J.,Lohr, T.A.,Elefante, L.,Shearin, J.,Matico, R.,Su, J.L.,Xue, Y.,Liu, F.,Genell, C.,Miller, R.E.,Tran, P.B.,Malfait, A.M.,Maier, C.C.,Matheny, C.J. Translational development of an ADAMTS-5 antibody for osteoarthritis disease modification. Osteoarthr. Cartil., 23:1254-1266, 2015 Cited by PubMed Abstract: Aggrecanase activity, most notably ADAMTS-5, is implicated in pathogenic cartilage degradation. Selective monoclonal antibodies (mAbs) to both ADAMTS-5 and ADAMTS-4 were generated and in vitro, ex vivo and in vivo systems were utilized to assess target engagement, aggrecanase inhibition and modulation of disease-related endpoints with the intent of selecting a candidate for clinical development in osteoarthritis (OA). PubMed: 25800415DOI: 10.1016/j.joca.2015.02.778 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.6 Å) |
Structure validation
Download full validation report